Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products

Hematopathology and Molecular Hematology

Volumn 11, Issue 3-4, 1998, Pages 173-183

  Luthra, R ^a   Pugh, W C ^a   Waasdorp, M ^a   Morris, W ^a   Cabanillas, F ^a   Chan, P K ^a   Sarris, A H ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

ALCL; ALK; Long range PCR; NPM; t(2; 5) chromosomal translocation

Indexed keywords

NUCLEOPHOSMIN; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER GENETICS; CARBOXY TERMINAL SEQUENCE; CHILD; CHIMERA; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENE FUSION; GENE MAPPING; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTRON; LARGE CELL LYMPHOMA; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENE AMPLIFICATION; HUMANS; INTRONS; LYMPHOMA, LARGE-CELL, KI-1; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031730327     PISSN: 10828893     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994.
2. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK: Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033-1039, 1989.
3. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379-390, 1989.
4. Feuerstein N, Spiegel S, Mond JJ: The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol 107:1629-1642, 1988.
5. Feuerstein N, Randazzo PA: In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. Exp Cell Res 194:289-296, 1991.
6. Pulford K, Lamant L, Morris SW, Wood KM, Stroud D, Delsol G, Mason DY: Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89:1394-1404, 1977.
7. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14:2175-2188, 1997.
8. Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T: Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA 93:4181-4186, 1996.
9. Bischof D, Pulford K, Mason DY, Morris SW: Role of the nucleophosmin (NPM) portion of the nonHodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 17:2312-2325, 1997.
10. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW: Retrovirus-mediated gene transfer of NMP-ALK causes lymphoid malignancy in mice. Blood 90:2901-2910, 1997.
11. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris SW: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416-3422, 1995.
12. Lopetagui JR, Sun LH, Chan KC, Gaffey MJ, Frierson HF, Kamel OW, Koo C, Glaskin C, Weiss LM: Association of t(2;5) in CD30-positive anaplastic large cell lymphoma vs Hodgkin's disease. Mod Pathol 8:115A, 1995.
13. Ngan B: The presence of transcripts of the fusion of kinase gene ALK to nucleophosmin gene NPM in the t(2;5)(p23;q35) translocation defines subsets of non-Hodgkin's lymphoma with or without CD30 (Ki-1) expression and Hodgkin's disease. Mod Pathol 8:118A, 1995.
14. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeid M: Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86:2321-2328, 1995.
15. Yee HT, Ponzoni M, Merson A, Scarpa A, Menestrina F, Chilosi M, Pittaluga S, DeWolf-Peeters C, Frizzera, G, Ighirami G: Chimeric NPM-ALK transcripts of t(2;5) in anaplastic large cell lymphoma (ALCL) and Hodgkin's disease (HD). Mod Pathol 8:124A, 1995.
16. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873-2877, 1994.
17. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AF: Large-cell anaplastic lymphoma-specific translocation (t[2;5]p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? Lancet 345:8790, 1995.
18. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648-3652, 1994.
19. Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mon N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S: Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 86:1954-1960, 1995.
20. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC: Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 86:3517-3521, 1995.
21. Lamant L, Meggetto F, Al Saati T, Brugieres L, Bressac de Paillerets B, Dastugue N, Bernheim A, Ruble H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Deisol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p-80 immunostaining. Blood 87:284-291, 1996.
22. Waggott W, Lo Y-MD, Bastard C, Gatter KC, Leroux D, Mason DY, Boultwood J, Wainscoat JS: Detection of NPM-ALKDNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 89:905907, 1995.
23. Sams AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC: Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not on other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 88:1771-1779, 1996.
24. Sarris AH, Luthra R, Padimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris S, Pugh W: Rapid amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Ann Oncol 8(Suppl 2):59-63, 1997.
25. Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R, Cleary ML: Lack of involvement of the c-ftns and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155-2164, 1989.
26. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview, NY, 1989.
27. Chan PK, Chan FY, Morris SW, Xhong Z: Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region. Nucl Acids Res 25:1225-1232, 1997.
28. Ladanyi M, Cavalchire G: Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site. Genes Chromosomes Cancer 15:173-177, 1996.
29. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM: Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(ll;14) chromosome translocation. Nature 315:340-343,1985.
30. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM: The t(14,18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393, 1985.
31. Haiti P, Lipp M: Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals. Mol Cell Biol 7:2037-2045, 1987.
32. Tonegawa S: Somatic generation of antibody diversity. Nature 302:575-581, 1983.
33. Bae YS, Kawasaki I, Ikeda H, Liu FF: Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro. Proc Natl Acad Sci USA 85:2076-2080, 1988.
34. Rabbitts P, Douglas J, Fischer P, Nacheva E, Karpas A, Catovsky D, Mélo J, Baer R, Stinson M, Rabbitts T: Chromosome abnormalities at Ilql3 in B cell tumours. Oncogene 3:99-103, 1988.
35. Kalo S, Tachibana K, Takayama N, Kataoka H, Yoshida MC, Takano T: Genetic recombination in a chromosomal translocation t(2;8)(pll;q24) of a Burkitt's lymphoma cell line, KOBK101. Gene 97:239-244, 1991.
36. Chen SJ, Chen Z, d'Auriol L, Le Coniat M, Grausz D, Berger R: Phi +bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene. Oncogene 4:195-202, 1989.
37. Sowerby SJ, Kennedy MA, Fitzgerald PH, Morris CM: DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias. Oncogene 8:16791683, 1993.
38. Sams AH, Luthra R, Kliche K-O, McBride A, Andreeff M, Cabanillas F: The t(2;5)(p23;q35) is not detectable in normal donor peripheral blood mononuclear cells by polymerase chain reaction amplification (PCR) of genomic DNA. Blood 90(Suppl l):335a, 1997.